UNSPSC 51183617: Insulin porcine

This classification denotes a therapeutic insulin with the molecular formula C256H381N65O76S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AVT680JB39, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-, but more generally known as insulin porcine, which bears US NIH Compound Identifier 16131098. European Medicines Agency schedules insulin porcine or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG.

Most nations, for tariff purposes, schedule insulin porcine under HS 29371200. SMILES:.

UNSPSC 51183617 Insulin porcine, a Commodity code, covers porcine (pork-derived) insulin products procured by state and local health systems, corrections agencies, and public health departments for diabetic patient care and management. State and local governments purchase porcine insulin primarily through pharmacy procurement channels for inpatient and outpatient therapeutic use, though this specific insulin type has become less common as synthetic and human-recombinant formulations have gained market share over the past two decades.

The source provides no recent state or local contract opportunities under this code. The absence of recent solicitations reflects the declining clinical and procurement prevalence of porcine insulin in modern public-sector healthcare purchasing, where human-recombinant and analog insulins now dominate formulary selections and bid cycles.